Koers Procter & Gamble Health Ltd NSE India S.E.
Aandelen
Farmaceutische producten
slotkoers
Andere beurzen
|
||
- INR | - |
Omzet 2022 | 11,14 mld. 134 mln. 125 mln. | Omzet 2023 | 12,3 mld. 147 mln. 138 mln. | Marktkapitalisatie | 87,13 mld. 1,05 mld. 977 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | 1,92 mld. 23,09 mln. 21,59 mln. | Nettowinst (verlies) 2023 | 2,3 mld. 27,53 mln. 25,73 mln. | EV/omzet 2022 | 5,95 x |
Nettoliquiditeiten 2022 | 3,17 mld. 37,97 mln. 35,5 mln. | Nettoliquiditeiten 2023 | 4,23 mld. 50,74 mln. 47,44 mln. | EV/omzet 2023 | 6,74 x |
K/w-verhouding 2022 |
36,1
x | K/w-verhouding 2023 |
38
x | Werknemers | - |
Dividendrendement 2022 |
1,25% | Dividendrendement 2023 |
1,81% | Vrij verhandelbaar | 47,83% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Milind Thatte
CEO | Chief Executive Officer | 55 | 01-04-18 |
Lokesh Chandak
DFI | Director of Finance/CFO | - | 01-04-23 |
Zeal Shah
CMP | Compliance Officer | - | 01-07-21 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 86 | 17-01-84 | |
Director/Board Member | 66 | 15-11-21 | |
Rani Ajit Jadhav
BRD | Director/Board Member | 75 | 05-02-15 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,62% | 43,34 mld. | |
+20,44% | 21,96 mld. | |
+10,86% | 14,09 mld. | |
+13,07% | 13,64 mld. | |
+37,46% | 11,43 mld. | |
-8,59% | 6,86 mld. | |
-0,05% | 6,79 mld. | |
-8,87% | 5,73 mld. | |
+8,46% | 5,22 mld. |
- Beurs
- Aandelen
- Koers PGHL
- Koers